Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akira Asai is active.

Publication


Featured researches published by Akira Asai.


ACS OMEGA | 2018

Structural and Thermodynamic Basis of the Enhanced Interaction between Kinesin Spindle Protein Eg5 and STLC-type Inhibitors

Hideshi Yokoyama; Jun-ichi Sawada; Kohei Sato; Naohisa Ogo; Nanami Kamei; Yoshinobu Ishikawa; Kodai Hara; Akira Asai; Hiroshi Hashimoto

For a better understanding of protein–inhibitor interactions, we report structural, thermodynamic, and biological analyses of the interactions between S-trityl-l-cysteine (STLC) derivatives and the motor domain of kinesin spindle protein Eg5. Binding of STLC-type inhibitors to Eg5 was enthalpically driven and entropically unfavorable. The introduction of a para-methoxy substituent in one phenyl ring of STLC enhances its inhibitory activity resulting from a larger enthalpy gain possibly due to the increased shape complementarity. The substituent fits to a recess in the binding pocket. To avoid steric hindrance, the substituted STLC is nudged toward the side opposite to the recess, which enhances the interaction of Eg5 with the remaining part of the inhibitor. Further introduction of an ethylene linkage between two phenyl rings enhances Eg5 inhibitory activity by reducing the loss of entropy in forming the complex. This study provides valuable examples of enhancing protein–inhibitor interactions without forming additional hydrogen bonds.


Archive | 2009

Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient

Akira Asai; Kenji Matsuno; Naohisa Ogo; Takane Yokotagawa; Osamu Takahashi; Yasuto Akiyama; Tadashi Ashizawa; Tadashi Okawara


Archive | 2010

1,3,4-OXADIAZOLE-2-CARBOXAMIDE COMPOUND

Akira Asai; Kenji Matsuno; Naohisa Ogo; Osamu Takahashi; Yoshiaki Masuda; Ayumu Muroya; Yasuto Akiyama; Tadashi Ashizawa; Tadashi Okawara


Archive | 2008

Eg5 inhibitor and agent for treatment of cell proliferative disease containing the same

Akira Asai; Jun-ichi Sawada; Kenji Matsuno; Naohisa Ogo; Nobutaka Fujii; Shinya Oishi


Archive | 2013

Novel cysteine compound and salt thereof

Akira Asai; 章良 浅井; Naohisa Ogo; 尚久 小郷; Jun-ichi Sawada; 潤一 澤田; Akihiro Hashimoto; 章弘 橋本


Archive | 2009

Nouveau derive de biaryle

Akira Asai; Jun-ichi Sawada; Kenji Matsuno; Naohisa Ogo; Junji Nishigaki; Masayoshi Kojima


Archive | 2000

Inhibiteurs de telomerase et leurs procedes d'utilisation

Allison C. Chin; Ryan Holcomb; Mieczyslaw A. Piatyszek; Upinder Singh; Richard L. Tolman; Tsutomu Akama; Yutaka Kanda; Akira Asai; Yoshinori Yamashita; Kaori Endo; Hiroyuki Yamaguchi


Archive | 1996

UCK14-Verbindungen UCK14 connections

Tamio Mizukami; Akira Asai; Yoshinori Yamashita; Ritsuko Katahira; Atsuhiro Hasegawa; Keiko Ochiai; Shiro Akinaga


Archive | 1996

Uch-15-verbindungen Uch-15 connectors

Tamio Mizukami; Akira Asai; Yoshinori Yamashita; Hirofumi Nakano; Shingo Kakita; Youichi Uosaki; Keiko Ochiai; Tadashi Ashizawa; Akira Mihara


Archive | 1996

Uch-15 connections

Tamio Mizukami; Akira Asai; Yoshinori Yamashita; Hirofumi Nakano; Shingo Kakita; Youichi Uosaki; Keiko Ochiai; Tadashi Ashizawa; Akira Mihara

Collaboration


Dive into the Akira Asai's collaboration.

Top Co-Authors

Avatar

Naohisa Ogo

Kumamoto Health Science University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiko Ochiai

Nagaoka University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tamio Mizukami

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Osamu Takahashi

Kumamoto Health Science University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge